Coming Soon
Path Therapeutics has developed a novel zebrafish drug screening platform that combines precision genomics and whole animal bioenergetics to uncover new therapeutic leads and novel druggable targets for epilepsy.
Path Therapeutics has developed a novel zebrafish drug screening platform that combines precision genomics and whole animal bioenergetics to uncover new therapeutic leads and novel druggable targets for epilepsy.